
Johnson & Johnson Vision's Podcast
Vision Matters, brought to you by Johnson & Johnson Vision, is a series of conversations, enabling eye care professionals to reflect on their practice and ensure they can continue to provide excellence in patient care. Eye care professionals in the UK can gain 1 CPD point by listening to an episode and completing the accompanying exercise available on www.jnjvisionpro.co.uk.
Important Safety Information
ACUVUE® Contact Lenses are indicated for vision correction. As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Contact lenses should not be used in case of eye infections or any other eye conditions, or in case of a systemic disease that may affect the eye. For complete information, including contraindications, precautions and adverse reactions, please consult the Instructions for Use or visit our website www.jnjvisionpro.co.uk
Johnson & Johnson Vision's Podcast
Vision Matters Podcast Episode 2: Presbyopia: Contact Lens Options
This episode focuses on the various contact lens options for our presbyopic patients. Our guest host, Dr Katherine Evans, Senior Lecturer at Cardiff University, speaks to two newly qualified Optometrists, Diana Harkin & Hafsah Raja, who share their key tips for success when fitting presbyopic patients with contact lenses. We also hear from Dr Debarun Dutta, Lecturer and Researcher at Aston University, about the merits of multifocal contact lenses and importance of ocular surface assessment in maximising success.
PP2023MLT6460
Important Safety Information
ACUVUE® Contact Lenses are indicated for vision correction. As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Contact lenses should not be used in case of eye infections or any other eye conditions, or in case of a systemic disease that may affect the eye. For complete information, including contraindications, precautions and adverse reactions, please consult the Instructions for Use or visit our website www.jnjvisionpro.co.uk
© Johnson & Johnson Medical Ltd 2025.